PDLIM4 anticorps (AA 251-330)

N° du produit ABIN762326

Détail du produit anti-PDLIM4 anticorps

Antigène: PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))

Épitope: AA 251-330

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PDLIM4 est non-conjugé

Application: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (Cultured Cells) (IF (cc))

Réactivité croisée: Humain

Homologie: Mouse,Rat,Dog,Cow,Pig,Horse,Chicken,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human RIL

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur PDLIM4

Antigène: PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))

Autre désignation: Ril (PDLIM4 Produits)

Synonymes: anticorps MGC75597, anticorps PDLIM4, anticorps RIL, anticorps Ril, anticorps H-Rev18, anticorps PDZ and LIM domain 4, anticorps PDZ and LIM domain 4 L homeolog, anticorps PDZ and LIM domain protein 4, anticorps pdlim4, anticorps pdlim4.L, anticorps PDLIM4, anticorps pdli4, anticorps Pdlim4

Sujet:

Synonyms: Enigma homolog, LIM domain protein, LIM protein RIL, PDLIM 4, PDLIM4, PDZ and LIM domain 4, PDZ and LIM domain protein 4, Reversion induced LIM protein, PDLI4_HUMAN.

Background: RIL, also known as PDLIM4 is a putative tumor suppressor gene. RIL is transcriptionally repressed by hypermethylation in a variety of tumors including breast and prostate. The difference in methylation status of RIL between normal and cancerous tissues is being investigated as to determine the use of RIL as a potential biomarker. Two isoforms of human RIL one have been identified.

ID gène: 8572

UniProt: P50479